May 2005
Volume 46, Issue 13
Jump To...
Free
ARVO Annual Meeting Abstract  |   May 2005
Is There an Association of Topical Ocular Hypotensive Medication With Lens Opacification And Visual Function?: Evidence From the Ocular Hypertension Treatment Study (OHTS)
M. Kass; J. Beiser; D. Herman; K. Lamping; J. Soltau; M. Gordon
Author Affiliations & Notes
  • M. Kass
    Ophthalmology, Washington University, St. Louis, MO
  • J. Beiser
    Ophthalmology, Washington University, St. Louis, MO
  • D. Herman
    Ophthalmology, Mayo Foundation, Rochester, MN
  • K. Lamping
    Ophthalmology, University Suburban Health Center, South Euclid, OH
  • J. Soltau
    Ophthalmology, University of Louisville, Louisville, KY
  • M. Gordon
    Ophthalmology, Washington University, St. Louis, MO
  • Footnotes
    Commercial Relationships  M. Kass, Pfizer F; J. Beiser, None; D. Herman, None; K. Lamping, None; J. Soltau, None; M. Gordon, None.
  • Footnotes
    Support  NIH Grant EY09307, EY09341
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 2448. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Is There an Association of Topical Ocular Hypotensive Medication With Lens Opacification And Visual Function?: Evidence From the Ocular Hypertension Treatment Study (OHTS)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      M. Kass, J. Beiser, D. Herman, K. Lamping, J. Soltau, M. Gordon; Is There an Association of Topical Ocular Hypotensive Medication With Lens Opacification And Visual Function?: Evidence From the Ocular Hypertension Treatment Study (OHTS) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):2448.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract
 
Abstract:
 

To determine if topical ocular hypotensive medication is associated with lens opacification and/or decreased visual function. We compared participants in the observation group to those the medication group using the last data prior to June, 2002 for: a. cataract surgery or combined cataract/filtering surgery, b. best corrected ETDRS visual acuity, c. mean deviation and foveal threshold from Humphrey visual fields. After June 2002, topical medication was offered to participants in the observation group. Masked LOCS III gradings were conducted between March 2003 and October 2004.

 

 

 

Image not available
View OriginalDownload Slide
Image not available
View OriginalDownload Slide
In OHTS, little evidence was found to support the hypothesis that topical ocular hypotensive medication is associated with lens opacification or decreased visual function.

 

 
Keywords: cataract • visual acuity 
© 2005, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept